Q1 2025 Holdings
Filed 2025-05-13 | 24 holdings | $500.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $333.1M | 3,658,361 | 66.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $32.2M | 22,032,040 | 6.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $30.0M | 5,376,344 | 6.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $24.3M | 3,457,815 | 4.8% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $19.4M | 1,272,214 | 3.9% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $15.2M | 1,875,000 | 3.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $12.2M | 505,645 | 2.4% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $7.6M | 2,411,575 | 1.5% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $6.9M | 7,032,770 | 1.4% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $4.3M | 4,690,431 | 0.9% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $3.8M | 2,970,022 | 0.8% |
| Celcuity Inc(CELC) | COM | 15102K100 | $3.5M | 349,406 | 0.7% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $2.6M | 1,675,000 | 0.5% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $1.7M | 2,362,348 | 0.3% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $1.5M | 953,834 | 0.3% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $972.8K | 715,295 | 0.2% |
| Nextcure Inc | COM | 65343E108 | $908.6K | 1,891,763 | 0.2% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $458.3K | 277,777 | 0.1% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $250.4K | 626,109 | 0.1% |
| Senseonics Hldgs Inc(SENS1GBP) | COM | 81727U105 | $28.5K | 43,426 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA) | CL A NEW | 37611X209 | $16.7K | 2,928 | 0.0% |